Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 114 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Doumas, Michael  [Clear All Filters]
Journal Article
Athyros, V. G., Katsiki N., & Doumas M. (2018).  Editorial: Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis.. Curr Vasc Pharmacol. 16(2), 104-106.
Bress, A. P., King J. B., Kreider K. E., Beddhu S., Simmons D. L., Cheung A. K., et al. (2017).  Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial.. Diabetes Care.
Mitsiou, E., Boutari C., Kotsis V., Georgianou E., Doumas M., Karagiannis A., et al. (2018).  Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension.. Curr Vasc Pharmacol. 16(4), 393-400.
Athyros, V. G., Tziomalos K., Doumas M., Sfikas G., & Karagiannis A. (2017).  The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins.. Curr Pharm Des. 23(10), 1477-1483.
Vogiatzakis, N., Tsioufis C., Georgiopoulos G., Thomopoulos C., Dimitriadis K., Kasiakogias A., et al. (2017).  Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis.. J Hypertens. 35(9), 1750-1757.
Imprialos, K. P., Stavropoulos K., Doumas M., Karagiannis A., & Athyros V. G. (2017).  The effect of SGLT2 inhibitors on cardiovascular events and renal function.. Expert Rev Clin Pharmacol. 10(11), 1251-1261.
Athyros, V. G., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2013).  Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review.. Curr Med Res Opin. 29(10), 1263-74.
Papademetriou, V., Lovato L., Tsioufis C., Cushman W., Applegate W. B., Mottle A., et al. (2017).  Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study.. Am J Nephrol. 45(2), 136-145.
Doumas, M., Lazaridis A., & Reklou A. (2013).  Effects of hypertension and antihypertensive therapy on sexual function in the elderly: the jury is still out.. J Hypertens. 31(9), 1917-8.
Doumas, M., Imprialos K. P., & Stavropoulos K. (2018).  Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.. N Engl J Med. 378(10), 967.
Papadopoulou, E., Varouktsi A., Lazaridis A., Boutari C., & Doumas M. (2015).  Erectile dysfunction in chronic kidney disease: From pathophysiology to management.. World J Nephrol. 4(3), 379-87.
Kokkinos, P., Myers J., Doumas M., Faselis C., Manolis A., Pittaras A., et al. (2009).  Exercise capacity and all-cause mortality in prehypertensive men.. Am J Hypertens. 22(7), 735-41.
Kokkinos, P., Manolis A., Pittaras A., Doumas M., Giannelou A., Panagiotakos D. B., et al. (2009).  Exercise capacity and mortality in hypertensive men with and without additional risk factors.. Hypertension. 53(3), 494-9.
Kokkinos, P., Myers J., Faselis C., Panagiotakos D. B., Doumas M., Pittaras A., et al. (2010).  Exercise capacity and mortality in older men: a 20-year follow-up study.. Circulation. 122(8), 790-7.
Doumas, M., Papademetriou V., Faselis C., & Kokkinos P. (2013).  Gender differences in hypertension: myths and reality.. Curr Hypertens Rep. 15(4), 321-30.
Patoulias, D., Stavropoulos K., Imprialos K., Katsimardou A., Kalogirou M-S., Koutsampasopoulos K., et al. (2019).  Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of RCTs.. Diabetes Res Clin Pract. 158, 107927.
Kokkinos, P., Doumas M., Myers J., Faselis C., Manolis A., Pittaras A., et al. (2009).  A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure.. Blood Press. 18(5), 261-7.
Viigimaa, M., Doumas M., Vlachopoulos C., Anyfanti P., Wolf J., Narkiewicz K., et al. (2011).  Hypertension and sexual dysfunction: time to act.. J Hypertens. 29(2), 403-7.
Katsiki, N., Doumas M., Athyros V. G., & Karagiannis A. (2015).  Hyperuricemia as a risk factor for cardiovascular disease.. Expert Rev Cardiovasc Ther. 13(1), 19-20.
Narayan, P., Doumas M., Kumar A., Faselis C. J., Myers J. N., Pittaras A., et al. (2017).  Impact of Cardiorespiratory Fitness on Mortality in Black Male Veterans With Resistant Systemic Hypertension.. Am J Cardiol. 120(9), 1568-1571.
Stergiou, G. S., Doumas M., Kollias A., & Papademetriou V. (2016).  Important practice lessons from the SPRINT study beyond the blood pressure goal: all well known and now confirmed.. J Am Soc Hypertens. 10(8), 613-7.
Stavropoulos, K., Imprialos K. P., Doumas M., Karagiannis A., & Papademetriou V. (2019).  Insomnia and hypertension: A misty landscape.. J Clin Hypertens (Greenwich). 21(6), 835-837.
Kokkinos, P. F., Faselis C., Myers J., Panagiotakos D., & Doumas M. (2013).  Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study.. Lancet. 381(9864), 394-9.
Doumas, M., & Douma S. (2009).  Interventional management of resistant hypertension.. Lancet. 373(9671), 1228-30.
Tsioufis, C., Kokkinos P., Macmanus C., Thomopoulos C., Faselis C., Doumas M., et al. (2010).  Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk.. J Hypertens. 28(11), 2299-308.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.